DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
Provided By GlobeNewswire
Last update: Oct 30, 2025
Châtillon, France, October 30, 2025
DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today announced upcoming participation in the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting, November 6 - 10, in Orlando, Florida.
Read more at globenewswire.comNASDAQ:DBVT (12/12/2025, 8:24:12 PM)
18.37
-1.05 (-5.43%)
Find more stocks in the Stock Screener
DBVT Latest News and Analysis
